ANTONIO CARRASCO, MD
Surgeon and Clinical Hematologist graduated from the National University of San Marcos, Lima, Peru. Postdoctoral fellow of the University of Texas, MD Anderson Cancer Center, Houston, USA. UU. Master in Health Service Management from the ESAN University, Lima-Peru.
Former Medical Director for Latin America of Bayer Schering Pharma in Oncology and Hematology in Mexico City DF, Mexico. Former Head of Hematology Service of the Hematopoietic Progenitor Transplant Department of the National Institute of Child Health San Borja, Lima, Peru. Hematologist doctor of the Anglo-American Clinic and Delgado Clinic - AUNA. Member of the LATP (Latin American Training Program) of the American Society of Hematology.
Clinical development in the area of onco-hematology (myeloma, leukemia and myelodysplasia), hematopoietic progenitor transplantation, regenerative therapy, cryobiology, coagulation and hemostasis, tissue engineering and flow cytometry.
Cameron is a biomedical engineer who specializes in regenerative medicine and applied cellular therapies. He was trained at the University of Michigan in Ann Arbor where he received a bachelor’s degree in biomedical engineering in 2017 and a master’s degree with a focus in biomaterials and regenerative medicine in 2018. He developed expertise in stem cell biology and protein engineering during his studies and has applied his knowledge to develop novel cellular therapies for both regenerative and oncologic indications. His research interests include designing membrane proteins to be inserted into cells or exosomes for enhanced therapeutic activity. He has designed novel CAR-T receptors designed to target solid tumors that are being investigated for safety and efficacy, and he has developed unique protocols for harvesting exosomes derived from mesenchymal stem cells that have the potential to be applied to a wide variety of indications.